Positive association between stress hyperglycemia ratio and pulmonary infection in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention

Previous studies have shown that the stress hyperglycemia ratio (SHR), a parameter of relative stress-induced hyperglycemia, is an excellent predictive factor for all-cause mortality and major adverse cardiovascular events (MACEs) among patients with ST-segment elevation myocardial infarction (STEMI...

Full description

Saved in:
Bibliographic Details
Published in:Cardiovascular diabetology 2023-03, Vol.22 (1), p.76-76, Article 76
Main Authors: Lin, Zehuo, Liang, Xueqing, Zhang, Yeshen, Dai, Yining, Zeng, Lin, Chen, Weikun, Kong, Siyu, He, Pengcheng, Duan, Chongyang, Liu, Yuanhui
Format: Article
Language:English
Subjects:
Anemia
Angioplasty
Cardiology
Cardiovascular diseases
Cerebral infarction
Coronary vessels
Glucose
Heart attacks
Heart surgery
Hemodialysis
Hemoglobin
Hospitalization
Humans
Hyperglycemia
Hyperglycemia - diagnosis
Hyperglycemia - epidemiology
Hypertension
Infections
Laboratories
Leukocytes
Mortality
Myocardial infarction
Percutaneous Coronary Intervention - adverse effects
Percutaneous intervention
Pulmonary infection
Regression analysis
Risk factor
Risk Factors
ST Elevation Myocardial Infarction - diagnosis
ST Elevation Myocardial Infarction - surgery
ST-segment elevation myocardial infarction
Statistical significance
Stress hyperglycemia ratio
Stroke
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Previous studies have shown that the stress hyperglycemia ratio (SHR), a parameter of relative stress-induced hyperglycemia, is an excellent predictive factor for all-cause mortality and major adverse cardiovascular events (MACEs) among patients with ST-segment elevation myocardial infarction (STEMI). However, its association with pulmonary infection in patients with STEMI during hospitalization remains unclear. Patients with STEMI undergoing percutaneous coronary intervention (PCI) were consecutively enrolled from 2010 to 2020. The primary endpoint was the occurrence of pulmonary infection during hospitalization, and the secondary endpoint was in-hospital MACEs, composed of all-cause mortality, stroke, target vessel revascularization, or recurrent myocardial infarction. A total of 2,841 patients were finally included, with 323 (11.4%) developing pulmonary infection and 165 (5.8%) developing in-hospital MACEs. The patients were divided into three groups according to SHR tertiles. A higher SHR was associated with a higher rate of pulmonary infection during hospitalization (8.1%, 9.9%, and 18.0%, P 
ISSN:1475-2840
1475-2840
DOI:10.1186/s12933-023-01799-3